. Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries. Am J Physiol Heart Circ Physiol 288: H129 -H132, 2005. First published September 16, 2004; doi:10.1152/ ajpheart.00574.2004.-Vasoconstriction via ␣2-receptors is known to be sensitive to acidic pH, but little is known about the pH sensitivity of P2X receptors. ATP is a cotransmitter released with norepinephrine from the sympathetic nerves and causes vasoconstriction via P2X purinergic receptors on vascular smooth muscle. We hypothesized that reductions in pH would attenuate P2X-mediated vasoconstriction in iliofemoral artery rings. Twenty-five rats were killed, and the iliac and femoral arteries were dissected out and placed in modified Krebs-Henseleit buffer. The arteries were cut into 2-mm sections and mounted in an organ tissue bath. Tension (g) was measured during a potassium chloride and norepinephrine challenge (maximal tension). The arteries were then exposed to ␣,-methylene ATP (10 Ϫ7 -10 Ϫ3 M; n ϭ 13) or phenylephrine (10 Ϫ7 -10 Ϫ4 M; n ϭ 6) with a tissue bath pH of 7.8, 7.4, and 7.0. Dose-response curves were fit with nonlinear regression analysis to calculate the EC50 and slope. The peak tension with ␣,-methylene ATP was lower during pH 7.0 (1.37 Ϯ 0.09 g) compared with pH 7.8 (1.90 Ϯ 0.12 g). EC50 was highest with pH 7.4 (Ϫ5.38 Ϯ 0.18 log M ␣,-methylene ATP) and lowest with pH 7.0 (Ϫ4.9 Ϯ 0.10 log M ␣,-methylene ATP). The slopes of the doseresponse curves were not different. Pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid) abolished contraction caused by the addition of ␣,-methylene ATP (n ϭ 6). There was no effect of pH on phenylephrine dose-response curves. These data indicate that the vasoconstrictor response to ␣,-methylene ATP is sensitive to pH and that lower pH attenuates the response of P2X purinergic receptors. hydrogen ion; vascular smooth muscle; pH PURINERGIC RECEPTORS ARE PRESENT in most organ systems in the body, and there is accumulating evidence that they play an important role in vascular control in the tail, ear, mesenteric, and skeletal muscle vascular beds (3-5, 7, 20). In skeletal muscle, vasoconstriction is predominantly mediated by norepinephrine release from adrenergic neurons, which stimulates both ␣ 1 -and ␣ 2 -postjunctional receptors on vascular smooth muscle. However, there is growing evidence that P2X purinergic receptors on vascular smooth muscle play an important role in vasoconstriction at rest and during exercise (4, 5). These receptors are activated by ATP, which is a cotransmitter released with norepinephrine from the sympathetic nerves (7,9,11,19).In the skeletal muscle vascular bed, physiological conditions (e.g., exercise) and pathological conditions (e.g., peripheral arterial insufficiency) cause a decrease in pH that may influence the regulation of vascular control (2, 13, 21). The pH sensitivity of adrenergic receptors in conduit arteries varies widely across vascular beds, but data suggest that the sensitivity of ␣ 2 -receptors is decreased with acidic pH (12,15,1...